midodrine has been researched along with Cruveilhier-Baumgarten Syndrome in 2 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Cruveilhier-Baumgarten Syndrome: Liver cirrhosis with intrahepatic portal obstruction, HYPERTENSION, and patent UMBILICAL VEINS.
Excerpt | Relevance | Reference |
---|---|---|
"The hepatorenal syndrome is a well-recognized complication of advanced cirrhosis and is usually associated with an accelerated course to death unless liver transplantation is performed." | 2.53 | Emerging hepatic syndromes: pathophysiology, diagnosis and treatment. ( Bertino, G; Crisafulli, E; Demma, S; Koukias, N; Privitera, G; Purrello, F; Spadaro, L; Tsochatzis, EA, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rajaram, P | 1 |
Spivey, J | 1 |
Fisher, M | 1 |
Bertino, G | 1 |
Privitera, G | 1 |
Purrello, F | 1 |
Demma, S | 1 |
Crisafulli, E | 1 |
Spadaro, L | 1 |
Koukias, N | 1 |
Tsochatzis, EA | 1 |
1 review available for midodrine and Cruveilhier-Baumgarten Syndrome
Article | Year |
---|---|
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
Topics: Acute Kidney Injury; Adrenal Insufficiency; Ascites; Creatinine; Evidence-Based Medicine; Hepatorena | 2016 |
1 other study available for midodrine and Cruveilhier-Baumgarten Syndrome
Article | Year |
---|---|
Novel role of midodrine in pulmonary hypertension in liver transplant candidates.
Topics: Adrenergic alpha-1 Receptor Agonists; End Stage Liver Disease; Female; Humans; Hypertension, Portal; | 2016 |